CPU 86017 suppression of arrhythmias induced by ischemia/reperfusion, ouabain, aconitine, and elevation of ventricular fibrillatory threshold

Drug Development Research

Volumn 39, Issue 2, 1996, Pages 184-190

  Dai, De Zai ^a   An, Lu Fan ^a   Wang, You Qun ^a   Huang, Jun ^a   Zhang, Hua ^a   Dai, Dong ^a   Yu, Feng ^a   Zhang, Meng Hui ^a   Huang, Zhen Ya ^a   Peng, Si Xun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Aconitine; Antiarrhythmic agent; CPU 86017; Ventricular fibrillation threshold

Indexed keywords

ACONITINE; ANTIARRHYTHMIC AGENT; BERBERINE; CHANGROLIN; CPU 86017; LIDOCAINE; MEXILETINE; OUABAIN; PROPAFENONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAM; GUINEA PIG; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HYPERTROPHIC CARDIOMYOPATHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RAT;

EID: 12644306847     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199610)39:2<184::AID-DDR12>3.0.CO;2-C     Document Type: Article

References (20)

1. Bacaner MB (1983): Bethanidine sulfate as an antifibrillatory drug. In Scriabine A (ed): New Drugs Annual: Cardiovascular Drugs. New York: Raven Press, pp 69-92.
2. Colatsky TJ (1996): Antiarrhythmic drugs: Where are we going? Pharmaceut News 2:17-23.
3. Dai DZ (1989): The new concepts and strategic on development of antiarrhythmic agents. Prog Pharmaceut Sci 13:4-9.
4. Dai DZ, Rong P, Shen W (1989): Protection of tetrahydroberberine derivatives on acute infarction in rats. J China Pharmaceut Univ 20:278-282.
5. Dai DZ, Rong P, Huang J, Liu J, Cheng JH, Chen YH (1991): Antiarrhythmic activities of six indole derivatives of changrolin. Acta Pharmacol Sin 12:411-418.
6. Dai DZ, An LE Huang DY, Sun RY (1996): Orthogonal analysis of aggravating effect of alpha- and beta-agonists and leukocyte on reperfusion-induced arrhythmias and ventricular fibrillation in Langendorff's rat heart. Acta Pharmacol Sin 17:146-148.
7. Echt DS, Iieibson PR, Mitchell LB, and the CAST Investigators (1991): Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmias Suppression Trial. N Engl J Med 324:781-788.
8. Euler D, Scanion P (1988): Comparative effects of antiarrhythmic drugs on the ventricular fibrillation threshold. J Cardiovasc Pharmacol 11:291-298.
9. Finance O, Manning A, Chatelain P (1996): Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol and lidocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol 26:670-676.
10. Goldstein S (1989): Mechanisms and prevention of sudden death in coronary heart disease. J Clin Pharmacol 29:413-417.
11. Harron DWG, Brezina M, Lillie C, Robinger W (1988): Antifibrillatory properties of alinidine after coronary artery occlusion in rats. Eur J Pharmacol 110:301-308.
12. Huang WM, Gan YQ, Ren JY, Shi HM (1990): Berberine treatment of ventricular tachycardias. Chin J Cardiovasc 18:166-166.
13. Lynch JJ, Coskey LA, Montgomery DG, Lucchesi BR (1986): Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. Am Heart J 109:949-968.
14. Miyazawa X, Hashimoto H, Uematsu T, Nakashima M (1989): Electrophysiological abnormalities and enhanced reperfusion arrhythmia in the isolated hearts of hyperthyroid rats. Br J Pharmacol 97:1093-1106.
15. Reiser HJ, Sullivan ME (1986): Antiarrhythmic drug therapy: New drugs and changing concepts. Fed Proc 45:2206-2212.
16. Tosaki A, Balint S, Ssekerea L (1988): Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium and calcium content. J Cardiovasc Pharmacol 12:621-628.
17. Wang Y, Li DX (1987): Anti-arrhythmic action of l-tetrahydropalmatine. Acta Pharmacol Sin 8:337-340.
18. Yu F, Dai DZ, Tang YQ (1996): Effect of CPU 86017 on ion channel evidenced by electrophysiological approaches. Acta Pharmacol Sin 17:80 (abstr).
19. Zhang QY, He GY, Wu XD (1991): Anti-arrhythmic effects of tetrahydroberberine. Chin Pharmacol Bull 7:469-462.
20. Zhao DH, Zhao GD, Sheng BH, Wang FC (1988): The experimental anti-arrhythmic effects of l-stepholidine. Chin Pharmacol Bull 4:36-38.